Giuseppe Giannini

7.8k total citations
109 papers, 4.1k citations indexed

About

Giuseppe Giannini is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Giuseppe Giannini has authored 109 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 37 papers in Cancer Research and 34 papers in Oncology. Recurrent topics in Giuseppe Giannini's work include Cancer Genomics and Diagnostics (24 papers), BRCA gene mutations in cancer (19 papers) and Colorectal Cancer Treatments and Studies (16 papers). Giuseppe Giannini is often cited by papers focused on Cancer Genomics and Diagnostics (24 papers), BRCA gene mutations in cancer (19 papers) and Colorectal Cancer Treatments and Studies (16 papers). Giuseppe Giannini collaborates with scholars based in Italy, United Kingdom and United States. Giuseppe Giannini's co-authors include Vincenzo Sorrentino, Alberto Gulino, Isabella Screpanti, Sandra Mammarella, Antonio Conti, Rino Rappuoli, Giulio Ratti, Lucia Di Marcotullio, Luigi Frati and Carlo Capalbo and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Giuseppe Giannini

107 papers receiving 4.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Giuseppe Giannini	2.7k	820	747	535	496	109	4.1k
Peter A. Greer	3.5k 1.3×	814 1.0×	504 0.7×	469 0.9×	992 2.0×	140	6.0k
Kevin D. Brown	3.9k 1.4×	1.4k 1.7×	1.0k 1.4×	470 0.9×	466 0.9×	90	5.6k
Sean Bong Lee	2.8k 1.0×	564 0.7×	449 0.6×	475 0.9×	540 1.1×	83	4.1k
Elena V. Ivanova	3.1k 1.1×	984 1.2×	727 1.0×	569 1.1×	565 1.1×	80	4.7k
Rachel Toth	4.0k 1.5×	776 0.9×	478 0.6×	393 0.7×	581 1.2×	84	5.6k
Claudio Sette	6.5k 2.4×	858 1.0×	1.3k 1.7×	797 1.5×	1.1k 2.2×	179	8.9k
Dirk Geerts	3.4k 1.3×	708 0.9×	731 1.0×	337 0.6×	690 1.4×	120	5.4k
Robert Latek	5.4k 2.0×	936 1.1×	509 0.7×	496 0.9×	1.2k 2.4×	31	7.6k
Tomohiko Maehama	6.2k 2.3×	1.1k 1.4×	798 1.1×	340 0.6×	937 1.9×	66	7.6k
Shomit Sengupta	4.6k 1.7×	1.4k 1.7×	705 0.9×	418 0.8×	671 1.4×	16	6.5k

Countries citing papers authored by Giuseppe Giannini

Since Specialization

Citations

This map shows the geographic impact of Giuseppe Giannini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Giannini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Giannini more than expected).

Fields of papers citing papers by Giuseppe Giannini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Giannini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Giannini. The network helps show where Giuseppe Giannini may publish in the future.

Co-authorship network of co-authors of Giuseppe Giannini

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Giannini. A scholar is included among the top collaborators of Giuseppe Giannini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Giannini. Giuseppe Giannini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

D’Onofrio, Luca, Stefano Di Giulio, Carmen Mignogna, et al.. (2025). IFN-α Neutralizing Antibodies Distinguish LADA From Early-onset Type 1 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 110(9). 2565–2572. 1 indexed citations

Bufalieri, Francesca, Giuseppe Giannini, Gianluca Canettieri, et al.. (2024). SMURF1 and SMURF2 directly target GLI1 for ubiquitination and proteasome-dependent degradation. Cell Death Discovery. 10(1). 498–498. 1 indexed citations

Derme, Martina, Mauro Ceccanti, Giuseppe Giannini, et al.. (2024). Prenatal Alcohol Exposure and Metabolic Disorders in Pediatrics: The Role of the Oxidative Stress—A Review of the Literature. Children. 11(3). 269–269. 4 indexed citations

Gaggianesi, Miriam, Francesca Bufalieri, Enrico De Smaele, et al.. (2024). MYC upstream region orchestrates resistance to PI3K inhibitors in cancer cells through FOXO3a-mediated autophagic adaptation. Oncogene. 43(46). 3349–3365. 3 indexed citations

Nicolazzo, Chiara, Giuseppe Giannini, Francesco Del Giudice, et al.. (2024). Exploring the utility of a NGS multigene panel to predict BCG response in patients with non-muscle invasive bladder cancer. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 33(3). 723–731. 1 indexed citations

Capuano, Cristina, Ombretta Turriziani, Antonio Angeloni, et al.. (2023). Impact of SARS-CoV-2 vaccination on FcγRIIIA/CD16 dynamics in Natural Killer cells: relevance for antibody-dependent functions. Frontiers in Immunology. 14. 1285203–1285203. 3 indexed citations

Valentini, Virginia, Valentina Silvestri, Giulia Pomati, et al.. (2023). Molecular profiling of male breast cancer by multigene panel testing: Implications for precision oncology. Frontiers in Oncology. 12. 1092201–1092201. 7 indexed citations

Petroni, Marialaura, Francesca Fabretti, Stefano Di Giulio, et al.. (2022). A gene dosage‐dependent effect unveils NBS1 as both a haploinsufficient tumour suppressor and an essential gene for SHH‐medulloblastoma. Neuropathology and Applied Neurobiology. 48(6). e12837–e12837. 4 indexed citations

Nicolazzo, Chiara, Francesca Belardinilli, Annarita Vestri, et al.. (2022). RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study. Cancers. 14(3). 802–802. 15 indexed citations

10.

Pelullo, Maria, Carmine Nicoletti, Zein Mersini Besharat, et al.. (2019). Kras/ADAM17-Dependent Jag1-ICD Reverse Signaling Sustains Colorectal Cancer Progression and Chemoresistance. Cancer Research. 79(21). 5575–5586. 27 indexed citations

11.

Nicolussi, Arianna, Francesca Belardinilli, Valentina Silvestri, et al.. (2019). Identification of novel BRCA1 large genomic rearrangements by a computational algorithm of amplicon-based Next-Generation Sequencing data. PeerJ. 7. e7972–e7972.

12.

Nicolussi, Arianna, Francesca Belardinilli, Valeria Colicchia, et al.. (2019). Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer. PeerJ. 7. e6661–e6661. 14 indexed citations

13.

Raimondi, Cristina, Chiara Nicolazzo, Francesca Belardinilli, et al.. (2019). Detecting the disappearance of RAS-mutant clones in the plasma of patients with RAS-mutant mCRC to select patient candidates for anti-EGFR treatment and to monitor resistance to treatment. Annals of Oncology. 30. iv38–iv38. 2 indexed citations

14.

Veschi, Veronica, Zhihui Liu, Ty C. Voss, et al.. (2017). Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma. Cancer Cell. 31(1). 50–63. 72 indexed citations

15.

Presutti, Dario, et al.. (2015). MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells. PLoS ONE. 10(11). e0143333–e0143333. 20 indexed citations

16.

Forloni, Matteo, Sonia Albini, Loredana Cifaldi, et al.. (2010). NF-κB, and not MYCN, Regulates MHC Class I and Endoplasmic Reticulum Aminopeptidases in Human Neuroblastoma Cells. Cancer Research. 70(3). 916–924. 62 indexed citations

17.

Smaele, Enrico De, Elisabetta Ferretti, Marianna Pelloni, et al.. (2008). An Integrated Approach Identifies Nhlh1 and Insm1 as Sonic Hedgehog-regulated Genes in Developing Cerebellum and Medulloblastoma. Neoplasia. 10(1). 89–IN36. 41 indexed citations

18.

Giannini, Giuseppe, Fabio Cerignoli, C Rinaldi, et al.. (2002). Human MRE11 is inactivated in mismatch repair‐deficient cancers. EMBO Reports. 3(3). 248–254. 159 indexed citations

19.

Giannini, Giuseppe, Lucia Di Marcotullio, Guidalberto Manfioletti, et al.. (2000). Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status. British Journal of Cancer. 83(11). 1503–1509. 38 indexed citations

20.

Giannini, Giuseppe, Lucia Di Marcotullio, Francesca Zazzeroni, et al.. (1997). 2-Aminopurine Unravels a Role for pRB in the Regulation of Gene Expression by Transforming Growth Factor β. Journal of Biological Chemistry. 272(8). 5313–5319. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact